Brolucizumab in polypoidal choroidal vasculopathy.

Sharma A, Parachuri N, Kumar N, Kuppermann BD, Loewenstein A, Bandello F

DOI: 10.1080/14712598.2022.2094239
Published: 2022 Jul
Container: Expert opinion on biological therapy
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/14712598.2022.2094239,
  title = {Brolucizumab in polypoidal choroidal vasculopathy.},
  author = {Sharma A and Parachuri N and Kumar N and Kuppermann BD and Loewenstein A and Bandello F},
  year = {2022},
  journal = {Expert opinion on biological therapy},
  doi = {10.1080/14712598.2022.2094239},
  url = {https://doi.org/10.1080/14712598.2022.2094239}
}

RIS

TY  - JOUR
TI  - Brolucizumab in polypoidal choroidal vasculopathy.
AU  - Sharma A
AU  - Parachuri N
AU  - Kumar N
AU  - Kuppermann BD
AU  - Loewenstein A
AU  - Bandello F
PY  - 2022
JO  - Expert opinion on biological therapy
DO  - 10.1080/14712598.2022.2094239
UR  - https://doi.org/10.1080/14712598.2022.2094239
ER  -

APA

A, S., N, P., N, K., BD, K., A, L., & F, B. (2022). Brolucizumab in polypoidal choroidal vasculopathy.. Expert opinion on biological therapy. https://doi.org/10.1080/14712598.2022.2094239

Source records

pubmed · retrieved 2026-09-25T14:51:09.295Z